{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T06:00:15Z","timestamp":1783749615874,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T00:00:00Z","timestamp":1438905600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12094-015-1371-2","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T03:31:10Z","timestamp":1438831870000},"page":"317-321","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The impact of prostate gland dimension in genitourinary toxicity after definitive prostate cancer treatment with moderate hypofractionation and volumetric modulated arc radiation therapy"],"prefix":"10.1007","volume":"18","author":[{"given":"R.","family":"Mazzola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Fersino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ricchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Giaj Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Di Paola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sicignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Naccarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"1371_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2009.07.1691","volume":"78","author":"G Arcangeli","year":"2010","unstructured":"Arcangeli G, Saracino B, Gomellini S, Petrongari MG, Arcangeli S, Sentinelli S, et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2010;78:11\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1371_CR2","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","volume":"23","author":"H Lukka","year":"2005","unstructured":"Lukka H, Hayter C, Julian JA, Warde P, Morris WJ, Gospodarowicz M, et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol. 2005;23:6132\u20138.","journal-title":"J Clin Oncol"},{"key":"1371_CR3","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ijrobp.2012.02.049","volume":"84","author":"S Arcangeli","year":"2012","unstructured":"Arcangeli S, Strigari L, Gomellini S, Saracino B, Petrongari MG, Pinnar\u00f2 P, et al. Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2012;84:1172\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1371_CR4","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2010.07.170","volume":"78","author":"DA Kuban","year":"2010","unstructured":"Kuban DA, Nogueras-Gonzalez GM, Hamblin L. Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation. Int J Radiat Oncol Biol Phys. 2010;78:S58\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"1371_CR5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00066-012-0171-7","volume":"188","author":"F Alongi","year":"2012","unstructured":"Alongi F, Fogliata A, Navarria P, Tozzi A, Mancosu P, Lobefalo F, et al. Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer. Strahlenther Onkol. 2012;188(11):990\u20136.","journal-title":"Strahlenther Onkol"},{"key":"1371_CR6","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2013.51.1972","volume":"31","author":"A Pollack","year":"2013","unstructured":"Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, et al. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol. 2013;31:3860\u20138.","journal-title":"J Clin Oncol"},{"key":"1371_CR7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijrobp.2010.07.1984","volume":"81","author":"EE Yeoh","year":"2011","unstructured":"Yeoh EE, Botten RJ, Butters J, Di Matteo AC, Holloway RH, Fowler J. Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial. Int J Radiat Oncol Biol Phys. 2011;81:1271\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1371_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","volume":"13","author":"D Dearnaley","year":"2012","unstructured":"Dearnaley D, Syndikus I, Sumo G, Bidmead M, Bloomfield D, Clark C, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol. 2012;13:43\u201354.","journal-title":"Lancet Oncol."},{"issue":"10","key":"1371_CR9","first-page":"4537","volume":"33","author":"F Alongi","year":"2013","unstructured":"Alongi F, Cozzi L, Fogliata A, Iftode C, Comito T, Clivio A, et al. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer. Anticancer Res. 2013;33(10):4537\u201343.","journal-title":"Anticancer Res"},{"key":"1371_CR10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2008.08.038","volume":"74","author":"N Muzio Di","year":"2009","unstructured":"Di Muzio N, Fiorino C, Cozzarini C, Alongi F, Broggi S, Mangili P, et al. Phase I-II study of hypofractionated simultaneous integrated boost with tomotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2009;74:392\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1371_CR11","doi-asserted-by":"crossref","unstructured":"Ferrera G, Mortellaro G, Mannino M, Caminiti G, Spera A, Figlia V, et al. Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales. Radiol Med. 2015.","DOI":"10.1007\/s11547-015-0555-8"},{"key":"1371_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","volume":"52","author":"DJ Brenner","year":"2002","unstructured":"Brenner DJ, Martinez AA, Edmundson GK, Mitchell C, Thames HD, Armour EP. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys. 2002;52:6\u201313.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1371_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2012.03.056","volume":"85","author":"P Pedicini","year":"2013","unstructured":"Pedicini P, Caivano R, Strigari L, Benassi M, Fiorentino A, Fusco V, In regard to Miralbell, et al. Re: dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5969 patients in seven international institutional datasets: alpha\/beta\u00a0=\u00a01.4 (0.9\u20132.2) Gy. Int J Radiat Oncol Biol Phys. 2013;85(1):10\u20131.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1371_CR14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14737140.2014.883282","volume":"14","author":"B Bari De","year":"2014","unstructured":"De Bari B, Fiorentino A, Arcangeli S, Franco P, D\u2019Angelillo RM, Alongi F. From radiobiology to technology: what is changing in radiotherapy for prostate cancer. Expert Rev Anticancer Ther. 2014;14(5):553\u201364.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"1371_CR15","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/030089161309900601","volume":"99","author":"B Bari De","year":"2013","unstructured":"De Bari B, Fiorentino A, Greto D, Ciammella P, Arcangeli S, Avuzzi B, et al. Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the Italian young radiation oncologist meeting. Tumori. 2013;99(6):637\u201349.","journal-title":"Tumori."},{"key":"1371_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PPO.0b013e3181976614","volume":"15","author":"M Ritter","year":"2009","unstructured":"Ritter M, Forman J, Kupelian P, Lawton C, Petereit D. Hypofractionation for prostate cancer. Cancer J. 2009;15:1\u20136.","journal-title":"Cancer J"},{"issue":"5","key":"1371_CR17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.ijrobp.2006.10.040","volume":"67","author":"V Vavassori","year":"2007","unstructured":"Vavassori V, Fiorino C, Rancati T, Magli A, Fellin G, Baccolini M, et al. Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys. 2007;67(5):1401\u201310.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1371_CR18","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2013.05.022","volume":"87","author":"H Le","year":"2013","unstructured":"Le H, Rojas A, Hughes R, Ostler P, Lowe G, Bryant L, et al. The influence of prostate volume on outcome after high-dose-rate brachytherapy alone for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2013;87(2):270\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1371_CR19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brachy.2007.10.005","volume":"7","author":"AT Monroe","year":"2008","unstructured":"Monroe AT, Faricy PO, Jennings SB, Biggers RD, Gibbs GL, Peddada AV. High-dose-rate brachytherapy for large prostate volumes (>\u00a0or 50\u00a0cc): uncompromised dosimetric coverage and acceptable toxicity. Brachytherapy. 2008;7:7\u201311.","journal-title":"Brachytherapy."},{"key":"1371_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0302-2838(03)00134-9","volume":"43","author":"T Krupski","year":"2003","unstructured":"Krupski T, Bissonette EA, Petroni GR, Theodorescu D. The impact of prostate volume following neoadjuvant androgen deprivation on quality of life and voiding symptoms in patients undergoing permanent prostate brachytherapy. Eur Urol. 2003;43:467\u201372.","journal-title":"Eur Urol"},{"key":"1371_CR21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0360-3016(01)01738-2","volume":"51","author":"T Sherertz","year":"2001","unstructured":"Sherertz T, Wallner K, Wang H, Sutlief S, Russell K. Long-term urinary function after transperineal brachytherapy for patients with large prostate glands. Int J Radiat Oncol Biol Phys. 2001;51:1241\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1371_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2007.05.051","volume":"70","author":"M Pinkawa","year":"2008","unstructured":"Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Nussen S, et al. Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(1):83\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1371_CR23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2009.11.023","volume":"79","author":"AA Aizer","year":"2011","unstructured":"Aizer AA, Anderson NS, Oh SC, Yu JB, McKeon AM, Decker RH, et al. The impact of pretreatment prostate volume on severe acute genitourinary toxicity in prostate cancer patients treated with intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011;79(2):379\u201384.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1371_CR24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1660.18172","volume":"100","author":"M Akin","year":"2014","unstructured":"Akin M, Oksuz DC, Iktueren B, Ambarcioglu P, Karacam S, Koca S, et al. Does rectum and bladder dose vary during the course of image-guided radiotherapy in the postprostatectomy setting? Tumori. 2014;100(5):529\u201335.","journal-title":"Tumori."},{"key":"1371_CR25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.critrevonc.2014.10.003","volume":"93","author":"RM D\u2019Angelillo","year":"2015","unstructured":"D\u2019Angelillo RM, Franco P, De Bari B, Fiorentino A, Arcangeli S, Alongi F. Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era. Critical Rev Oncol Hematol. 2015;93:136\u201348.","journal-title":"Critical Rev Oncol Hematol."},{"key":"1371_CR26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0090-4295(97)00168-4","volume":"49","author":"MJ Zelefsky","year":"1997","unstructured":"Zelefsky MJ, Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology. 1997;49:38\u201345.","journal-title":"Urology."},{"key":"1371_CR27","first-page":"1011","volume":"35","author":"M Roach 3rd","year":"1996","unstructured":"Roach M 3rd, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging andcomputerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1996;35:1011\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1371_CR28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00066-005-1383-x","volume":"181","author":"GM Villeirs","year":"2005","unstructured":"Villeirs GM, Van Vaerenbergh K, Vakaet L, Bral S, Claus F, De Neve WJ, et al. Interobserver delineation variation using CT versus combined CT\u00a0+\u00a0MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol. 2005;181:424\u201330.","journal-title":"Strahlenther Onkol"},{"key":"1371_CR29","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.critrevonc.2014.04.002","volume":"91","author":"B Bari De","year":"2014","unstructured":"De Bari B, Alongi F, Lestrade L, Giammarile F. Choline-PET in prostate cancer management: the point of view of the radiation oncologist. Crit Rev Oncol Hematol. 2014;91:234\u201347.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1371_CR30","doi-asserted-by":"crossref","unstructured":"Alongi F, Fersino S, Giaj Levra N, Mazzola R, Ricchetti F, Fiorentino A, et al. Impact of 18F-Choline PET\/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy. Clin Nucl Med. 2015.","DOI":"10.1097\/RLU.0000000000000841"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1371-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-015-1371-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-015-1371-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T23:20:19Z","timestamp":1567034419000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-015-1371-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1371"],"URL":"https:\/\/doi.org\/10.1007\/s12094-015-1371-2","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]}}}